Search for: "Chang, et al v. Bayer Corp, et al"
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
28 Nov 2011, 11:03 am
Bayer Corp. et al., No. [read post]
13 May 2010, 4:58 pm
Bayer Corp. et al. [read post]
27 Dec 2017, 10:14 am
In Dow Agrosciences, LLC, et al. v. [read post]
5 Jan 2014, 9:19 am
Bayer Corp. et al. [read post]
6 Feb 2014, 8:22 am
Bayer Corp. et al. [read post]
16 Jun 2011, 9:19 am
Maatman, Jr. and David Ross This morning the Supreme Court issued its long awaited and much anticipated ruling in Smith, et al. v. [read post]
8 Jul 2011, 1:36 pm
Cir. 2007), and Nilssen, et al. v. [read post]
27 Oct 2021, 5:15 am
Ltd., et al. v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
12 May 2009, 6:51 pm
Bayer AG and Bayer Corp., et al., No. 08-1194; cert. petition filed on Mar. 23, 2009, 2009 WL 797579. [read post]
7 Feb 2019, 12:08 pm
Campie, et al. [read post]
14 Aug 2020, 9:02 am
Bayer Healthcare et al., Case No. 5:20-cv-00102 (N.D. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces… [read post]
22 Dec 2011, 11:59 am
Bayer, 131 S. [read post]
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch) Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and then… [read post]
6 Dec 2010, 2:36 am
Fossil, Inc. et al (Docket Report) CAFC: Liability for offers to sell clarified: Transocean Offshore Deepwater Drilling, Inc. v. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
2 May 2008, 7:00 am
, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter in… [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
